| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA475: Dimethyl fumarate for treating moderate to severe plaque psoriasis |
|
Medicine details |
|
| Medicine name | dimethyl fumarate (Skilarence®) |
| Formulation | 30 mg, 150 mg tablet |
| Reference number | 2079 |
| Indication | Treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy |
| Company | Almirall Ltd |
| BNF chapter | Skin |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 26/04/2017 |
| NICE guidance | TA475: Dimethyl fumarate for treating moderate to severe plaque psoriasis |